Abstract. Biomedical domain and proteomics in particular are faced with an increasing volume of data. The heterogeneity of data sources implies heterogeneity in the representation and in the content of data. Data may also be incorrect, implicate errors and can compromise the analysis of experiments results. Our approach aims to ensure the initial quality of data during import into an information system dedicated to proteomics. It is based on the joint use of models, which represent the system sources, and ontologies, which are use as mediators between them. The controls, we propose, ensure the validity of values, semantics and data consistency during import process.
Introduction
Our research framework is in the biomedical domain and more specifically in clinical proteomics. Generally, proteomic platforms study proteins of organisms. Specifically, clinical proteomics is the study of characteristics of proteins in samples collected from groups of patients participating in a clinical study. A typical example is the discovery of biomarkers: 1) to identify and classify diseases, 2) to make early detection or diagnosis, and 3) to measure the response of patients to a therapy. The workflow of proteomic platforms is based on proteomics studies, involving a large number of samples data, from which the proteomic platforms extract relevant characteristics through experiments. In addition to the data used by the proteomic experiments, e.g. data resulting from mass spectrometer analysis, the statistical studies carried out after these experiments require accessing large volume of clinical data ranging from patient's characteristics and samples to diagnosed pathologies, transport conditions, and the conditions of storage of samples.
Proteomic platforms commonly use Laboratory Information Management System (LIMS) to manage different aspects of proteomics studies, varying from storing clinical information to realizing statistical studies following experiments on various equipments. There is a direct link between the imported clinical data in the LIM and the conclusions of a proteomic study. So, increasing the quality of data during the import process will lead to increase the accuracy of analysis results.
The information in the LIMS can easily be polluted by missing, redundant or even incorrect data without an effective management of data quality. Researchers (industries and academics) are increasingly interested in data quality [6, 21] . For many years, methods of prevention, audit and data cleaning are used to improve data quality in information systems. Berti-Équille lists four complementary approaches of data quality: diagnostic, adaptive, corrective and preventive ( [3] ). Diagnostic approaches mainly use statistical methods to detect errors in large amount of data. Adaptive approaches provide dynamic treatments for real time verification of constraints to ensure data quality. Corrective approaches attempt to detect errors by comparing data with real values and suggesting corrections. Finally, preventive approaches deal with evaluation of models and processes used in the LIMS.
To improve the quality of data in the context of proteomic information management, we propose a semi-automated data import method to garantee the quality of the data imported in the LIMS is not altered by changing the context of usage. To deal with these issues, our approach is based on three differents levels of controls. The first level deals with data source problems. These problems, often linked due to the particularities of the partner information systems, involve conflicts arise from the concepts manipulated by the systems. The next two levels are centered on data usage problems, which appear when data do not validate the context where they are imported. The context corresponds, on one hand, to data management within the LIMS, and on the other hand, to the domain logic. One level of control is used to ensure that data are complete and coherent as regards to the LIMS by checking constraints linked with the model. The other level of control checks data coherence according to the domain logic. This level deals with the creation of rules from the domain ontology to validate or unvalidate some data.
In the remainder of this paper, we illustrate through examples, in section 2, the issues of clinical data import. In section 3 we present tools and methods used in our approach. Sections 4 and 5 present our approach and its implementation in clinical proteomics. Finally, section 6 concludes this paper and offers opportunities we plan on this work. biological characteristics about patients, or Biobanks which organize the storage of samples, etc. Thus, for each proteomic study, the analyzed samples are associated to clinical data that must be imported from external sources into the LIMS.
To show the key characteristics of heterogeneity, we present some relevant examples of datasets received by a proteomic platforms. Tables 1 and 2 are extracted from clinical datasets provided to the proteomics platform by two clinicians (C1 and C2 respectively). Each row of the tables is associated with a biological sample. Data import issues can be divided in two categories: multiplicity of data sources and data usage. 
Problems related to the multiplicity of data sources
Partners, providing datasets, work in differents ways on samples. These various views on samples imply heterogeneity in terms of the datasets they provide to the proteomics platform.
Semantic conflicts have been studied extensively by researchers [15, 19, 26] . In summary, Goh identified three types of semantic heterogeneity [10] : 1) naming conflicts that occur in the presence of homonyms and synonyms, 2) scaling conflicts that arise when description granularities are not the same, and 3) confusion conflicts that arise when a word is used with two different meanings by two actors. Degoulet, working on message exchanged among actors of the biomedical domain, has highlighted the possibility of solving problems of semantics through the use of controlled vocabularies [8] .
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Data Semantics
The datasets in table 1 and 2 show various vocabularies for columns names. Clinician C1 (Table 1) uses Birth while C2 clinician (Table 2) uses Birthday. Obviously, the semantics of these two fields is the namely the patient's date of birth.
Data Format
We can also notice some differences on data formats. For example, in the case of birthday, clinician C1 chooses the format mmm-DD-YY while clinician C2 chooses the format MM/DD/YY. To match these data, data must be converted to the corresponding data format.
Field values and scale
Incompatible values (from different domains) can be used for corresponding fields in the tables. For example, the patient attribute about gender (Sex for clinician C1 and Gender for clinician C2), has as domain values {G,B} for clinician C1 (he is mainly working with children) and {M,F} for clinician C2.
Problems of scale can be divided in two categories. Measurement problems occur for example when a volume is expressed in µl and another in ml. The other problem concerns the granularity. For example, the same stage of development of a tumor can be described by several fields detailing the different characteristics of evolution in one source or by a single field that combine all characteristics in another source.
During the import process, these problems can be solved if the format and field of values are known and if automatic conversion methods are available. However, the problems related to semantics are much more complex and require technical representation of domain knowledge.
Problems related to the use of data
The management of biological and biomedical data raises many information design problems. Chen identified four technological challenges in the field of genomics [5] : 1) complexity of data (due to various granularities reflecting various aspects and specialities), 2) specialized knowledge (needed for capturing their semantics), 3) continuing evolution of knowledge and 4) variety of profiles of people (working in bioinformatics and trying to reach a consensus to meet a common goal). Among these challenges, data complexity is the most challenging problem in our context. Biological data are complex because they are heterogeneous [7] , incomplete, uncertain and inconsistent [31] . Despite these characteristics, the expertise of proteomic experiments requires high data quality to make pertinent conclusions.
Data completeness and coherence are a key concerns for many researchers. Chapter 2 of Han's book [13] gives a summary of different solutions dealing with missing or incorrect values. One solution is to ignore the tuple or the object.
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Another solution is to manually fill data gaps and modifify incorrect data. Other intermediates solutions use a constant, an average value or a decision tree to determine the missing data.
Completeness
As illustrate in table 1, sample S125 (second row in table 1) exhibits missing values for the fields used to identify the corresponding patient. Two solutions can be considered: reject the data due to the lack of identification values or use an annotation to distinguish the invalid data from others.
Coherence Data describing the same concept can sometimes define different characteristics for the concept. For example, in Table 1 even though samples S124 and S126 refer to the same patient (HG65), gender is Boy in S124 and Girl in S126, defining two differents genders for the same patient.
Domain Logic
The domain knowledge can highlight another problem. For example, the data in table 2 concern a proteomics study of breast cancer. Most samples of this datasets are taken from the breast of the patient. However, the sample S7 (third row in the table 2) is traken from the patient's liver. Is this a mistake made by the clinicain or a new detail that need to be studied ? Only a domain expert can answer this question. An implementation of a knowledge base to represent the rules defining the domain logic can be used to detect inconsistencies in the data.
To implement our approach, we need: 1) a model representing domain knowledge; 2) a model representing business knowledge (i.e. the business logic of the proteomics platform); 3) a model of the LIMS and 4) the schema of data sources.
Background
Linster presents two views on model building: 1) modelling to make sense and 2) modelling to implement systems [16] . Modeling to make sense is used to formally organize domain knowledge whereas modeling to implement, the most commonly used, consits in organizing the components of a system to execute them on a computer. In our proposal, we combine the two approaches by using ontologies to represent knowledge and models to implement data quality module.
Ontologies
According to [11] , an ontology is an explicit specification of a conceptualization . In practice, ontologies can be used to represent domain knowledge or as an aid to understand a system by separating data and domain concepts. There are various types of ontologies used for specific purposes. Van Heijst, define four types of ontologies ( [29] ): generic, domain, representation and application. In this article, we will only discuss domain and application ontologies.
Domain ontology
Domain ontology is used to represent consensual knowledge in a domain ( [24] ). It represents the key concepts of the domain linked by various relationships. The main relations used are specializations (is-a), synonyms and the generic relations (related-to). This type of ontology is used to ensure the consistency of semantics (also called semantic net by Wiederhold in [30] ) among various systems. Domain ontology can serve as scientific reference in exchanges with partners. The concepts and relationships are then used as a syntactic and semantic consensus. Many efforts are made in the biomedical field for structuring knowledge in the form of ontologies. The Gene Ontology consortium 1 produces a controlled vocabulary in the form of an ontology about roles of genes in protein expression ( [1] ).
Given the dynamic nature of knowledge, we chose to implement an evolving system to manage domain logic. Our system is based on "rules" defined on relationships among concepts of the domain ontology. Concerning information systems, business rules are formal expressions that constrain some aspects of a system. They structure, control and influence a system ( [12, 22] ). Recent works have shown the benefits of rules for Semantic Web ( [17, 14] ). In our approach we focus on rules for defining new part of knowledge that are not directly modeled in the ontology. Only domain experts can define pertinents rules to be taken into account to increase proteomics platform knowledge. The evolving characteristic of the rules system is given by decoupling knowledge (ontologies and rules) and implementation of the system.
Application ontology
An application ontology is used to represent the knowledge of implemented systems. Compared to domain ontologies, application ontologies respresent the reality of the information systems to which they are affiliated. An ontology of this type can be used in a system of cooperation among various partners in a domain. It often serves as a reference for technical meetings among system users, to determine if a concept of a system corresponds to another concept of another system. For example, two systems with patient identifiers, PatientNum and PatientCode, will refer to the same concept PatientId of the application ontology. In our approach, this type of ontology is used as a mediator among partners and LIMS schema.
Models
Models are representations of systems according to certain points of view. Among the modeling languages, one of the most used is probably the Unified Modeling Language (UML). UML defines several diagrams to describe several aspect (structural, behavioral, temporal, etc.) of a system or an application. Fowler defines three ways to use UML models in his book "UML Distilled " [9] : as sketches, as blueprints or as a programming language. According to Fowler, UML models are used mainly as sketches to help the understanding of ideas among project participants during meetings. They aren't focused on development. Blueprints are precise enough to be implemented by a developer. Using UML as a programming language allows immediate implementation of UML models into executable code: diagrams become the program's source code. In our approach, UML models are defined as blueprints, they will be accurate enough to be implemented by simple transformation into executable code.
Coupling ontologies and models

Spear ([27]) defines two dimensions for the construction of a domain description:
-the horizontal dimension (or relevance) determines the scope of information that must be included in the representation of knowledge; -the vertical dimension (or granularity) determines the accuracy of the representation of knowledge.
Ontologies, due to their mechanism of refinement and specialization are best suited to the vertical dimension of a domain. The horizontal axis is better supported by models that allow the aggregation of knowledge over large areas.
Ashenhurst asserts that the use of ontologies to guide semantics and thus the domain knowledge is relevant [2] . Our proposal incorporates these findings by using ontologies to support knowledge modeling and UML models (mainly class diagram) to define structure of system components.
Organization of data quality components
Our approach is mainly based on the use of ontologies as mediators among partner systems and LIMS system. The controls made during data import can check and detect some errors following three steps. The first step is to check semantics, domain and data format using an application ontology. The second step is to verify data completeness and coherence through the use of the components structure defined in the UML class diagram. The last step is to check business rules related to the domain knowledge. Once these three steps are performed, the validated data can be stored in the LIMS database. Figure 1 represents a summary view of models and ontologies organization used during this process.
Clinical data model used in the LIMS
The LIMS used by the proteomics platform maintains data in a relational database which can store identified and if necessary transformed data to ensure the relevance of search tools and data quality.
Clinical data model was realized by using UML class diagram and presents patient-specific data and their associations to pathologies (via a date of diagnosis, a patient may present several diseases) and to biological data samples. To store ontological information, we add domain "classifications" used by proteomic platforms. Diseases can be associated with a code complying to the International Classification of Diseases 2 proposed by the World Health Organisation. The class diagram follows the ICD structure Chapter -Section -Element to allow a more or less fine description. For example, a clinician may define a disease by ICD code C78.7 (Secondary malignant neoplasm of the liver) or by the code C00-D48 (malignant tumors) according to the accuracy of information provided . The cancer tumors may be associated with a code TNM (Tumor, Nodes, Metastasis) to define the extent of tumor in a patient's body.
Ontologies
Two ontologies are needed in our approach: a domain ontology to support the domain knowledge and an application ontology to support specific partners knowledge.
Domain ontology
The construction of this ontology followed a method based on "relevant questions" and by searching common concepts in the domain. According to Brusa [4] , relevant questions are questions posed by experts during their "investigations" and that the ontology can provide an answer for. Here is an example of The rules, we use in our approach, are based on associations among concepts of domain ontology. An example of "associations for rules" is shown on Figure 2 . It specifies which organs are affected by diseases. For this, we define a generic relation affectedOrgan linking the concept Anatomy (from the MeSH branch) and the concept Disease (from the ICD branch). Then, the expert must "specialize" knowledge by defining which organs are affected by diseases: e.g. the Liver is an organ affected by the pathology C78.7 (secondary malignant neoplasm of liver). A rule must then be created defining the validity of a sample if the pathology and the organ are mutually relevant.
Application ontology
The application ontology is used as a mediator between the models of partners and the model of the LIMS. It is designed in agreement with key partners and the proteomic platform. Each partners' schema has a match between the descriptors of data (classes, attributes, headers, etc.) and a concept of the ontology. Figure  3 is an extract of our application ontology. 
Mappings
We borrow the concept of mapping used in ontology alignment works ( [25, 23] ) to represent correspondences among concepts of two ontologies and among the concepts of the application ontology and the schema descriptors. We use two types of mappings: ontological mappings between two concepts of ontologies and ontology-schema mappings linking a ontological concept to a schema descriptor.
Ontological mappings
Ontological mappings M O are mappings of type 1..1 to express an equivalence between concepts. In our approach, this mapping is used to match the concepts of the application ontology to those of the domain ontology. The mappings are made during the construction of two ontologies and must be updated when one (or both) ontology (ies) evolve. For example, we have created the following ontological mapping: M O 1 (Anatomy DO , Location AO ) to match the concept Anatomy of the domain ontology DO and the concept Location of application ontology AO.
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We decide to make a loose coupling among application ontology and domain ontology because of their different degree of evolution. The domain ontology is not set to change often, because its concepts are adopted by many experts. The application ontology can be extended and modified at each arrival (possibly departure) of a partner. The loose coupling among these two ontologies allows us, when modifying an ontology, to not impact the other concepts.
Ontology-schema mappings Ontology-schema mappings M OS link the concepts of an application ontology to data schemas descriptors. The mappings can be of type 1..1 linking one concept of an ontology to one descriptor of the schema, type 1..n linking one concept of an ontology to several descriptors of the schema, or type n. .1 linking several concepts from ontology to one single descriptor. The mappings define what is the exact meaning of each schema descriptor. Descriptors of schemas are also linked by ontology-schema mappings with the data formats branch of the application ontology. For example in our LIMS, the descriptor BirthDate is mapped to the format DD/MM/YYYY while the birthday date of the schema of partner 1 (Birth) is linked to the format DD-MM-YY. So we have two types of ontology-schema mappings: 1) to define the meaning of the descriptors and 2) to define the data format. The joint use of these both types of mappings allows to find the conversion function required to transform values.
Each schema has its specific characteristics. The entry of a new partner in this system may in some cases be made without changing the application ontology. We only have to perform ontology-schema mappings among descriptors and application ontology. In other cases, it is necessary to change the application ontology concepts impacted by specializing concepts. Ontology-schema mappings corresponding to other partners will not be impacted by such changes. For example, if a new partner is defining the location of samples by the use of two descriptors, we can expand the concept of Location of application ontology in two "sub-concepts": Position and Depth.
Implementation of the approach
The implementation of our approach has three main steps. The first step involves the creation of objects based on the semantic definition and format of the data. The second step is to check coherence and completeness of the objects in accordance with the schema of our LIMS. The third and final step is to check the consistency of objects according to the domain logic. Figure 4 summarizes the various steps of our approach, for reasons of clarity, we do not show mappings present in Figure 1 . The first control concerns the semantics and data format. It uses ontologyschema mappings to determine semantics of each descriptor. Comparison of mappings performed on the LIMS' schema to those made on the partners' schema, hilights: 1) the correspondences among partners and LIMS descriptors, and 2) the conversion operations required to transform data values. The construction of objects is based on these two pieces of information. At the end of this step, we have "syntax objects".
Once the objects are created, we can check coherence and completeness. The use of UML class diagram as a structural model of our system allows you to specify optional and mandatory associations between objects. Thus we can identify association errors between objects. We can also verify the consistency of some data within objects. Biological material is rare, we can not reject all of the invalid data. Invalid objects are inserted into the database with an annotation.
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For example, the clinician at the source of data set will be questioned to determine the gender of the patient. The annotation prevents the use of the biological sample within an experiment.
Once the objects checked, the rule engine takes into account the facts, i.e. the newly created objects and knowledge, and rules. At the end of this process we obtain consistent objects that have successfully passed three controls, or we obtain invalid objects. The rules supported by our implementation of the engine are written in SWRL ( [14] ) in accordance with the DL-Safe restriction [18] . For example, the following rule: "a sample is valid if the disease for which it is studied and if the organ from which it comes are mutually relevant" will be defined as: The implementation of our approach describes in this article is included in the Clinical Module eClims 4 of open source LIMS ePims TM . Due to the confidentiality characteristic of proteomics data, we only could test our processes on only one dataset provided to the CLIPP 5 platform by a clinician. This dataset is a CSV file containing 345 samples and 64 relevant descriptors. We identified 114 samples which do not match overall quality. 9 of these 114 samples were not consistent and the rule engine found problems concerning the sex of patients. The remaining 105 samples present some problems of completeness.
Conclusion
Our data import system ensures the initial quality of clinical proteomics data. The implementation may require a major human investment especially during the ontologies creation. But this initial investment guarantee to each dataset coming from one source, the same overall quality. As our approach is center on the LIMS' system, the scalability of this method is acceptable because of the centralization of the components. Adding new sources, "only" require the creation of new ontology-schema mappings between the source schema and the application ontology.
The main perspective is the automatic creation of ontology-schema mappings, especially during the addition of a new partner. This improvement would almost allow complete automation of our approach. To this end, we are interested in papers related to automatic alignment of ontologies ( [20] ).
